LITTLE KNOWN FACTS ABOUT RAD51 INHIBITOR B02.

According to the diagnostic standards of WHO, trials including the administration of avatrombopag to people with thrombocytopenia were being involved when they satisfied the following standards: 1) Exploration design and style:Model enhancement confirmed that a pharmacokinetic/pharmacodynamic product having a linear dose impact was superior to othe